Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials

Affiliations

• ¹ Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
• ² University of Toronto, Markham, ON, Canada.
• ³ Lynderm Research, Markham, ON, Canada.
• ⁴ Department of Dermatology, University of California San Francisco, San Francisco, CA, USA.
• ⁵ Department of Health Sciences, Magna Graecia University, Catanzaro, Italy.
• ⁶ Department of Dermatology, University of Rochester Medical Center, Rochester, NY, USA.
• ⁷ Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
• ⁸ Sanofi, Chilly-Mazarin, France.
• ⁹ Sanofi, Bridgewater, NJ, USA.
• ¹⁰ Sanofi, Madrid, Spain.
• ¹¹ Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA. [email protected].